- All sections
- C - Chemistrymetallurgy
- C07H - Sugarsderivatives thereofnucleosidesnucleotidesnucleic acids
- C07H 19/16 - Purine radicals
Patent holdings for IPC class C07H 19/16
Total number of patents in this class: 778
10-year publication summary
|
67
|
72
|
74
|
83
|
62
|
63
|
47
|
32
|
22
|
24
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Illumina Cambridge Limited | 672 |
24 |
| Atea Pharmaceuticals, Inc. | 78 |
22 |
| The Trustees of Columbia University in the City of New York | 3643 |
15 |
| Gilead Sciences, Inc. | 2220 |
15 |
| Epizyme, Inc. | 359 |
14 |
| Dana-Farber Cancer Institute, Inc. | 2662 |
12 |
| Emory University | 1719 |
12 |
| Idenix Pharmaceuticals LLC | 59 |
12 |
| Osaka University | 3269 |
12 |
| Janssen Biopharma, Inc. | 32 |
12 |
| Centre National de La Recherche Scientifique | 11016 |
11 |
| The Scripps Research Institute | 1343 |
11 |
| Arcus Biosciences, Inc. | 164 |
10 |
| Roche Innovation Center Copenhagen A/S | 128 |
10 |
| Merck Sharp & Dohme Corp. | 2183 |
9 |
| Idenix Pharmaceuticals, Inc. | 44 |
8 |
| Ionis Pharmaceuticals, Inc. | 955 |
8 |
| The Regents of the University of California | 20720 |
7 |
| Janssen Pharmaceutica N.V. | 3171 |
7 |
| Janssen Pharmaceuticals, Inc. | 435 |
7 |
| Other owners | 540 |